Exagen Inc.

Last updated September 27, 2026

Organization details

Legal name
Exagen Inc.
Former names
Exagen Diagnostics Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8071 — Services-Medical Laboratories
Jurisdiction of incorporation
Delaware
Headquarters city
Vista
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
XGN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001274737
Wikidata ID
Q106435940

Board of directors

Chief executives

John Aballi · President and CEO
Dates unknown

Director election results

Annual meeting of June 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 3 other boards. 2 are in the same sector.

Network of Exagen Inc.'s board connections Aurinia Pharmaceuticals Inc Aurinia Pharmaceutical... Azenta Inc. Azenta Inc. Envoy Medical Inc. Envoy Medical Inc. Chas McKhann Chas McKhann Tina Susan Nova Tina Susan Nova Exagen Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$195,682
3 purchases by 1 insider
Sold, last 12 months
$591,598
6 sales by 3 insiders
Date Insider Transaction Shares Price Value
Nov 10, 2026 Chernett Jorey 10% owner Open-market purchase +7,085 $5.26 $37,267
Nov 9, 2026 Chernett Jorey 10% owner Open-market purchase +8,500 $6.35 $53,975
Nov 6, 2026 Chernett Jorey 10% owner Open-market sale −11,265 $6.14 $69,167
Oct 19, 2026 Chernett Jorey 10% owner Open-market purchase +14,000 $7.46 $104,440
Oct 16, 2026 John Aballi Director, Officer (President and CEO) Open-market sale −34,294 $7.87 $269,791
Sep 1, 2026 Black Jeffrey G. Officer (Chief Financial Officer) Open-market sale −20,614 $7.22 $148,833
Sep 1, 2026 Black Jeffrey G. Officer (Chief Financial Officer) Grant or award +1,571 $3.02 $4,744
Mar 12, 2026 Black Jeffrey G. Officer (Chief Financial Officer) Grant or award +75,000 $3.16 $237,000
Mar 12, 2026 John Aballi Director, Officer (President and CEO) Grant or award +150,000 — —
Mar 3, 2026 John Aballi Director, Officer (President and CEO) Open-market sale −15,698 $3.62 $56,827
Mar 3, 2026 John Aballi Director, Officer (President and CEO) Grant or award +2,535 $3.08 $7,808
Feb 27, 2026 Black Jeffrey G. Officer (Chief Financial Officer) Grant or award +1,511 $3.08 $4,654
Feb 24, 2026 John Aballi Director, Officer (President and CEO) Open-market sale −11,430 $3.61 $41,262
Feb 24, 2026 Black Jeffrey G. Officer (Chief Financial Officer) Open-market sale −1,584 $3.61 $5,718
Oct 16, 2025 John Aballi Director, Officer (President and CEO) Open-market sale −31,787 $11.82 $375,722

Organizations in the same sector, closest in location and size first.

Questions about Exagen Inc.

Who is the CEO of Exagen Inc.?

John Aballi is Exagen Inc.'s President and CEO.

How many directors are on Exagen Inc.'s board?

Exagen Inc.'s board has 11 directors: Ana Hooker, Brian Birk, Bruce C. Robertson, Chas McKhann, Ebetuel Pallares, Frank Stokes, John Aballi, Paul Kim, Scott D. Kahn, Tina Susan Nova and 1 other.

Are Exagen Inc. insiders buying or selling shares?

Over the last 12 months, Exagen Inc. insiders bought $195,682 of shares in 3 purchases and sold $591,598 of shares in 6 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="exagen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.